KDR and pulmonary emphysema: Vascular endothelial growth factor receptor (VEGFR) was reported to mediate the anti-inflammatory, anti-protease, and anti-apoptosis effects of the lung, hence contribute to an attenuation of emphysema and destructive pulmonary function in COPD [48].